‘Ashwagandha’ herbal extracts have shown that its withanolides components modulate proliferation of breast cancer tissue through induction of FOXO3a protein and pro-apoptotic protein BIM, leading to induction of apoptosis in breast cancer cells11. This evidence concerns the gene FOXO3 and breast carcinoma.